Antibodies against RNA hydrolyze RNA and DNA

Journal of Molecular Recognition

Volumn 21, Issue 5, 2008, Pages 338-347

  Krasnorutskii, Michael A ^a   Buneva, Valentina N ^a   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Antibodies against RNA; Hydrolysis of RNA and DNA

Indexed keywords

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANTINUCLEAR ANTIBODY; CATALYTIC ANTIBODY; CELLULOSE; DEOXYRIBONUCLEASE; DNA; DNA CELLULOSE; DNA-CELLULOSE; DRUG DERIVATIVE; IMMUNOGLOBULIN G; RIBONUCLEASE; RNA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; DRUG EFFECT; EVALUATION; HYDROLYSIS; IMMUNOLOGY; METABOLISM; RABBIT;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, CATALYTIC; CELLULOSE; DEOXYRIBONUCLEASES; DNA; HYDROLYSIS; IMMUNOGLOBULIN G; RABBITS; RIBONUCLEASES; RNA;

EID: 52649161971     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.906     Document Type: Article

References (49)

1. Akagi K, Murai K, Hirao N, Yamanaka M. 1976. Purification and properties of alkaline ribonucleases from human serum. Biochim. Biophys. Acta 442: 368-378.
2. Andrievskaia OA, Kanyshkova TG, Iamkovoi VI, Buneva VN, Nevinskii GA. 1997. Monoclonal antibodies to DNA hydrolyze RNA better than DNA. Dokl. Akad. Nauk 355: 401-403.
3. Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA. 2000. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit. 6: 460-470.
4. Andrievskaya OA, Buneva VN, Baranovskii AG, Gal'vita AV, Benzo ES, Naumov VA, Nevinsky GA. 2002. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol. Lett. 81: 191-198.
5. Bernardi G. 1971. In Hydrolysis: Other C-N Bonds, Phosphate Esters, PD Boyer (ed.). Academic Press: New York; 271-287.
6. Blanco F, Kalsi J, Isenberg DA. 1991. Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases. Clin. Exp. Immunol. 86: 66-70.
7. Buneva VN, Kanyshkova TG, Vlassov AV, Semenov DV, Khlimankov D, Breusova LR, Nevinsky GA. 1998. Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers. Appl. Biochem. Biotechnol. 75: 63-76.
8. Buneva VN, Kudryavtseva AN, Gal'vita AV, Dubrovskaya VV, Khokhlova OV, Kalinina IA, Galenok VA, Nevinsky GA. 2003. Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Moscow) 68: 890-900.
9. Crook EM, Mathias AP, Rabin BR. 1960. Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 2′:3′-phosphate. Biochem. J. 74: 234-238.
10. Dabelic N, Cices N. 1997. Clinical importance of antinuclear antibodies. Lijec Vjesn. 119: 236-242.
11. Fersht A. 1985. Enzyme Structure and Mechanism, 2nd edn. W.H. Freeman: New York.
12. Fisher BM, Grilley JE, Raines RT. 1998. A new remote subsite in ribonuclease A. J. Biol. Chem. 273: 34134-34138.
13. Fletcher MC, Kuderova A, Cygler M, Lee JS. 1998. Creation of a ribonuclease abzyme through site-directed mutagenesis. Nat. Biotechnol. 16: 1065-1067.
14. Founel S, Muller S. 2002. Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann. Med. Interne (Paris) 153: 513-519.
15. Gololobov GV, Chernova EA, Schourov DV, Smirnov IV, Kudelina IA, Gabibov AG. 1995. Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc. Natl Acad. Sci. USA 92: 254-257.
16. Gottieb AA, Shwartz RH. 1972. Antigen-RNA interactions. Cell Immunol. 5: 341-362.
17. Hachulla E, Dubucquoi S. 2004. Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis. Rev. Med. Interne 25: 442-447.
18. Hirokawa K, Takasaki Y, Takeuchi K, Kaneda K, Ikeda K, Hashimoto H, Ikeda R. 2002. Anti-TS1-RNA: characterization of novel antibodies against sequence-specific RNA by random RNA selection in patients with Sjogren's syndrome. J. Rheumatol. 29: 931-937.
19. Ikeda R, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H. 2003. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. J. Rheumatol. 30: 998-1005.
20. Irie M, Mikami F, Monma K, Ohgi K, Watanabe H, Yamaguchi R, Nagase H. 1984. Kinetic studies on the cleavage of oligouridilic acids and poly(U) by bovine pancreatic ribonuclease A. J. Biochem. 96: 89-96.
21. Kanyshkova TG, Semenov DV, Khlimankov D, Buneva VN, Nevinsky GA. 1997. DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett. 416: 23-26.
22. Keinan EE (ed.). 2005. Catalytic Antibodies. Wiley-VCH: Weinheim.
23. Kozyr A, Kolesnikov A, Aleksandrova ES, Sashchenko LP, Gnuchev N, Favorov PV, Kotelnikov MA, Iakhnina EI, Astsaturov IA, Prokaeva TB, Alekberova ZS, Suchkov SV, Gabibov AG. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 1998. 75: 45-61.
24. Krasnorutskii MA, Buneva VN, Nevinsky GA. Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities. J. Mol. Recognit. Apr 2008 30. PMID: 18446884 [PubMed].
25. Kubota T. 1977. Lessons from a monoclonal antibody to double-stranded DNA. J. Med. Dent. Sci. 44: 37-44.
26. Laskowski M. 1971. In The Enzymes. PD Boyer (ed.). Academic Press: New York; 4: 310-320.
27. Lee WY, Attallh NA, Gyenes L, Sehon AY. 1971. Studies of rabbit ribonucleases. Arch. Biochem. Biophys. 147: 270-283.
28. Marion TN, Krishan MR, Desai DD, Jou NT, Tillman DM. 1997. Monoclonal anti-DNA antibodies: structure, specificity, and biology. Methods 11: 3-113.
29. Mitsuhashi S, Saito R, Kurashige S, Yamashugi N. 1978. Ribonucleic acid in the immune response. Moll. Cell. Biochem. 20: 131-147.
30. Nevinsky GA, Buneva VN. 2002a. Human catalytic RNA- and DNA-hydrolyzing antibodies. J. Immunol. Methods 269: 235-249.
31. Nevinsky GA, Buneva VN. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7: 265-276.
32. Nevinsky GA, Buneva VN. 2005. Natural catalytic antibodies-abzymes, In Catalytic Antibodies. E Keinan (ed.). VCH-Wiley: Weinheim; 503-567.
33. Nevinsky GA, Kanyshkova TG, Semenov DV, Vlassov AV, Gal'vita AV, Buneva VN. 2000. Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol. 83: 115-129.
34. Nevinsky GA, Favorova OO, Buneva VN. 2002b. Catalytic antibodies: new characters in the protein repertoire. Protein-Protein Interactions. A. Molecular Cloning Manual. Cold Spring Harbor press: New York; 523-534.
35. Nishi Y. 2002. Evolution of catalytic antibody repertoire in autoimmune mice. J. Immunol. Methods 269: 213-233.
36. Odintsova ES, Kharitonova M, Baranovskii AG, Sizyakina LP, Buneva VN, Nevinsky GA. 2006. DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome. Mol. Biol. (Moscow) 40: 770-777.
37. Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244: 1158-1162.
38. Raz E, Ben-Bassat H, Davidi T, Shlomoz Z, Eilat D. 1993. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol. 23: 383-390.
39. Sato T, Uvhiumi T, Arakawa M, Kominami R. 1994. Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain. Clin. Exp. Immunol. 98: 35-39.
40. Semenov DV, Kanyshkova TG, Karotaeva NA, Krasnorutskii MA, Kuznetsova IA, Buneva VN, Nevinsky GA. 2004. Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit. 10: BR23-BR33.
41. Shapot VS. 1968. Nucleases. Medicina: Moscow; 95-125.
42. Shoenfeld Y, Ben-Yehuda O, Messinger Y, Bentwitch Z, Rauch J, Isenberg DI, Gadoth N. 1988. Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol. Lett. 17: 285-291.
43. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG. 1992. DNA hydrolyzing autoantibodies. Science 256: 665-667.
44. Sinohara H, Matsuura K. 2000. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appi. Biochem. Biotechnol. 83: 85-94.
45. Suck D. 1994. DNA recognition by DNase I. J. Mol. Recognit. 7: 65-70.
46. Tanaka H, Sasaki I, Yamashita K, Miyazaki K, Matuo Y, Yamashita J, Horio T. 1980. Affinity chromatography of porcine pancreas deoxyribonuclease I on DNA-binding sepharose under non-digestive conditions, using its substrate-binding site. J. Biochem. (Tokyo), 88: 797-806.
47. Tawfik DS, Chap R, Green BS, Sela M, Eshhar Z. 2002. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? Proc. Natl. Acad. Sci. USA 92: 2145-2149.
48. Vlassov A, Florentz C, Helm M, Naumov V, Buneva V, Nevinsky G, Giege R. 1998. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res. 26: 5243-5250. 20.
49. Yasuda T, Takeshita H, Nakajita H, Nakashima Y, Kishi K. 1997. Rabbit DNase I: purification from urine, immunological and proteochemical characterization, nucleotide sequence, expression in tissues, relationships with other mammalian DNases I and phylogenetic analysis. Biochem. J. 325: 465-473.